Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PGM2L1 | gCSI | pan-cancer | AAC | 0.21 | 0.0007 |
mRNA | FGF7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | CAP2 | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0007 |
mRNA | MAPK3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | ALDH3B1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | HSPG2 | gCSI | pan-cancer | AAC | 0.25 | 0.0007 |
mRNA | TRMT10B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | MEGF9 | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |
mRNA | SERF2 | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
mRNA | HSPB7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |